Cargando…

Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein

The downregulation of sclerostin in osteocytes mediates bone formation in response to mechanical cues and parathyroid hormone (PTH). To date, the regulation of sclerostin has been attributed exclusively to the transcriptional downregulation of the Sost gene hours after stimulation. Using mouse model...

Descripción completa

Detalles Bibliográficos
Autores principales: Gould, Nicole R, Williams, Katrina M, Joca, Humberto C, Torre, Olivia M, Lyons, James S, Leser, Jenna M, Srikanth, Manasa P, Hughes, Marcus, Khairallah, Ramzi J, Feldman, Ricardo A, Ward, Christopher W, Stains, Joseph P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032393/
https://www.ncbi.nlm.nih.gov/pubmed/33779549
http://dx.doi.org/10.7554/eLife.64393
_version_ 1783676210063081472
author Gould, Nicole R
Williams, Katrina M
Joca, Humberto C
Torre, Olivia M
Lyons, James S
Leser, Jenna M
Srikanth, Manasa P
Hughes, Marcus
Khairallah, Ramzi J
Feldman, Ricardo A
Ward, Christopher W
Stains, Joseph P
author_facet Gould, Nicole R
Williams, Katrina M
Joca, Humberto C
Torre, Olivia M
Lyons, James S
Leser, Jenna M
Srikanth, Manasa P
Hughes, Marcus
Khairallah, Ramzi J
Feldman, Ricardo A
Ward, Christopher W
Stains, Joseph P
author_sort Gould, Nicole R
collection PubMed
description The downregulation of sclerostin in osteocytes mediates bone formation in response to mechanical cues and parathyroid hormone (PTH). To date, the regulation of sclerostin has been attributed exclusively to the transcriptional downregulation of the Sost gene hours after stimulation. Using mouse models and rodent cell lines, we describe the rapid, minute-scale post-translational degradation of sclerostin protein by the lysosome following mechanical load and PTH. We present a model, integrating both new and established mechanically and hormonally activated effectors into the regulated degradation of sclerostin by lysosomes. Using a mouse forelimb mechanical loading model, we find transient inhibition of lysosomal degradation or the upstream mechano-signaling pathway controlling sclerostin abundance impairs subsequent load-induced bone formation by preventing sclerostin degradation. We also link dysfunctional lysosomes to aberrant sclerostin regulation using human Gaucher disease iPSCs. These results reveal how bone anabolic cues post-translationally regulate sclerostin abundance in osteocytes to regulate bone formation.
format Online
Article
Text
id pubmed-8032393
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-80323932021-04-12 Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein Gould, Nicole R Williams, Katrina M Joca, Humberto C Torre, Olivia M Lyons, James S Leser, Jenna M Srikanth, Manasa P Hughes, Marcus Khairallah, Ramzi J Feldman, Ricardo A Ward, Christopher W Stains, Joseph P eLife Cell Biology The downregulation of sclerostin in osteocytes mediates bone formation in response to mechanical cues and parathyroid hormone (PTH). To date, the regulation of sclerostin has been attributed exclusively to the transcriptional downregulation of the Sost gene hours after stimulation. Using mouse models and rodent cell lines, we describe the rapid, minute-scale post-translational degradation of sclerostin protein by the lysosome following mechanical load and PTH. We present a model, integrating both new and established mechanically and hormonally activated effectors into the regulated degradation of sclerostin by lysosomes. Using a mouse forelimb mechanical loading model, we find transient inhibition of lysosomal degradation or the upstream mechano-signaling pathway controlling sclerostin abundance impairs subsequent load-induced bone formation by preventing sclerostin degradation. We also link dysfunctional lysosomes to aberrant sclerostin regulation using human Gaucher disease iPSCs. These results reveal how bone anabolic cues post-translationally regulate sclerostin abundance in osteocytes to regulate bone formation. eLife Sciences Publications, Ltd 2021-03-29 /pmc/articles/PMC8032393/ /pubmed/33779549 http://dx.doi.org/10.7554/eLife.64393 Text en © 2021, Gould et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Cell Biology
Gould, Nicole R
Williams, Katrina M
Joca, Humberto C
Torre, Olivia M
Lyons, James S
Leser, Jenna M
Srikanth, Manasa P
Hughes, Marcus
Khairallah, Ramzi J
Feldman, Ricardo A
Ward, Christopher W
Stains, Joseph P
Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein
title Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein
title_full Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein
title_fullStr Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein
title_full_unstemmed Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein
title_short Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein
title_sort disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein
topic Cell Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032393/
https://www.ncbi.nlm.nih.gov/pubmed/33779549
http://dx.doi.org/10.7554/eLife.64393
work_keys_str_mv AT gouldnicoler disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein
AT williamskatrinam disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein
AT jocahumbertoc disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein
AT torreoliviam disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein
AT lyonsjamess disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein
AT leserjennam disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein
AT srikanthmanasap disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein
AT hughesmarcus disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein
AT khairallahramzij disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein
AT feldmanricardoa disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein
AT wardchristopherw disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein
AT stainsjosephp disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein